Microbio Co., Ltd.(TW:4128)
NT$13.45-0.10 (-0.74%)
TW:4128
Microbio Co., Ltd. financials statements
NT$13.45
At close:-0.10 (-0.74%)
Microbio Co., Ltd. (4128) Ratios
Microbio Co., Ltd. Ratios
TW:4128's free cash flow for Q2 2026 was NT$-394.83M. For the 2026 fiscal year, TW:4128's free cash flow was decreased by NT$-18.49M and operating cash flow was NT$-376.35M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.30 | 5.85 | 8.13 | 10.04 | 8.95 |
| Quick Ratio | 3.97 | 5.44 | 7.73 | 9.54 | 8.51 |
| Cash Ratio | 0.92 | 1.26 | 1.25 | 2.55 | 1.45 |
| Solvency Ratio | -0.23 | -0.41 | -0.76 | 0.42 | 0.03 |
| Operating Cash Flow Ratio | 0.10 | 0.99 | -0.24 | 0.32 | 0.11 |
| Short-Term Operating Cash Flow Coverage | 24.40 | 280.82 | -54.47 | 57.48 | 31.02 |
| Net Current Asset Value | NT$ 1.28B | NT$ 1.08B | NT$ 2.78B | NT$ 3.37B | NT$ 3.31B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.04 | 0.04 | 0.03 | 0.03 |
| Debt-to-Equity Ratio | 0.08 | 0.06 | 0.05 | 0.04 | 0.04 |
| Debt-to-Capital Ratio | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.38 | 1.35 | 1.25 | 1.25 | 1.26 |
| Debt Service Coverage Ratio | -44.13 | -83.35 | -117.60 | 46.85 | 5.44 |
| Interest Coverage Ratio | -34.68 | -44.52 | -68.61 | -45.74 | -36.28 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.16 | 1.07 | 1.12 | 0.89 | 0.96 |
| Net Debt to EBITDA | 0.08 | 0.06 | -0.00 | -1.60 | -4.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.78% | 39.24% | 37.95% | 40.15% | 41.49% |
| EBIT Margin | -49.62% | -73.61% | -86.12% | 9.17% | -12.66% |
| EBITDA Margin | -35.12% | -58.14% | -70.70% | 23.25% | 2.50% |
| Operating Profit Margin | -21.47% | -26.19% | -31.83% | -16.20% | -12.66% |
| Pretax Profit Margin | -50.24% | -74.20% | -86.58% | 8.82% | -13.01% |
| Net Profit Margin | -40.01% | -63.89% | -74.14% | 12.27% | -13.08% |
| Continuous Operations Profit Margin | -50.34% | -74.21% | -86.55% | 8.85% | -53.46% |
| Net Income Per EBT | 79.63% | 86.11% | 85.63% | 139.10% | 100.56% |
| EBT Per EBIT | 234.02% | 283.37% | 272.05% | -54.45% | 102.76% |
| Return on Assets (ROA) | -6.14% | -7.90% | -8.01% | 1.40% | -1.55% |
| Return on Equity (ROE) | -8.50% | -10.68% | -9.99% | 1.75% | -1.96% |
| Return on Capital Employed (ROCE) | -3.52% | -3.37% | -3.56% | -1.90% | -1.55% |
| Return on Invested Capital (ROIC) | -3.48% | -3.33% | -3.52% | -1.89% | -1.54% |
| Return on Tangible Assets | -6.22% | -8.01% | -8.11% | 1.42% | -1.58% |
| Earnings Yield | -6.97% | -5.67% | -4.41% | 0.72% | -0.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.36 | 5.64 | 18.41 | 17.93 | 21.33 |
| Payables Turnover | 6.64 | 7.48 | 6.02 | 8.59 | 8.18 |
| Inventory Turnover | 4.37 | 4.71 | 4.97 | 4.63 | 4.82 |
| Fixed Asset Turnover | 1.09 | 0.94 | 0.85 | 0.97 | 0.96 |
| Asset Turnover | 0.15 | 0.12 | 0.11 | 0.11 | 0.12 |
| Working Capital Turnover Ratio | 0.73 | 0.56 | 0.42 | 0.43 | 0.44 |
| Cash Conversion Cycle | 96.66 | 93.34 | 32.62 | 56.64 | 48.32 |
| Days of Sales Outstanding | 68.08 | 64.71 | 19.83 | 20.36 | 17.11 |
| Days of Inventory Outstanding | 83.52 | 77.45 | 73.44 | 78.79 | 75.80 |
| Days of Payables Outstanding | 54.93 | 48.82 | 60.64 | 42.51 | 44.60 |
| Operating Cycle | 151.59 | 142.16 | 93.26 | 99.15 | 92.92 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.14 | 0.90 | -0.21 | 0.25 | 0.10 |
| Free Cash Flow Per Share | 0.04 | 0.83 | -0.30 | 0.18 | -0.09 |
| Dividend Paid and CapEx Coverage Ratio | 1.36 | 13.17 | -1.82 | 2.29 | 0.52 |
| Capital Expenditure Coverage Ratio | 1.36 | 13.17 | -2.65 | 3.28 | 0.52 |
| Operating Cash Flow Coverage Ratio | 0.12 | 0.86 | -0.19 | 0.29 | 0.10 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.31 | -0.07 | 0.08 | 0.03 |
| Free Cash Flow Yield | 0.20% | 2.52% | -0.62% | 0.34% | -0.17% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -14.34 | -17.65 | -22.66 | 145.19 | -123.58 |
| Price-to-Sales (P/S) Ratio | 5.74 | 11.27 | 16.83 | 17.00 | 16.28 |
| Price-to-Book (P/B) Ratio | 1.22 | 1.88 | 2.27 | 2.42 | 2.44 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 494.65 | 39.64 | -160.56 | 297.25 | -580.46 |
| Price-to-Operating Cash Flow Ratio | 131.31 | 36.63 | -225.52 | 206.71 | 537.44 |
| Price-to-Earnings Growth (PEG) Ratio | 0.46 | 1.55 | 0.03 | -0.79 | 0.86 |
| Enterprise Value Multiple | -16.25 | -19.32 | -23.81 | 71.48 | 646.51 |
| Enterprise Value | 10.81B | 19.35B | 26.79B | 28.62B | 28.81B |
| EV to EBITDA | -16.25 | -19.32 | -23.81 | 71.48 | 646.51 |
| EV to Sales | 5.71 | 11.23 | 16.83 | 16.62 | 16.16 |
| EV to Free Cash Flow | 492.09 | 39.52 | -160.59 | 290.73 | -576.33 |
| EV to Operating Cash Flow | 130.63 | 36.52 | -225.56 | 202.18 | 533.62 |
| Tangible Book Value Per Share | 17.12 | 19.88 | 23.78 | 24.66 | 24.95 |
| Shareholders’ Equity Per Share | 15.17 | 17.52 | 21.08 | 21.60 | 21.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | -0.00 | -0.01 |
| Revenue Per Share | 3.22 | 2.93 | 2.84 | 3.08 | 3.26 |
| Net Income Per Share | -1.29 | -1.87 | -2.11 | 0.38 | -0.43 |
| Tax Burden | 0.80 | 0.86 | 0.86 | 1.39 | 1.01 |
| Interest Burden | 1.01 | 1.01 | 1.01 | 0.96 | 1.03 |
| Research & Development to Revenue | 0.19 | 0.23 | 0.25 | 0.15 | 0.48 |
| SG&A to Revenue | 0.42 | 0.43 | 0.44 | 0.41 | 0.58 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.46 |
| Income Quality | -0.11 | -0.41 | 0.10 | 0.93 | -0.23 |
Currency in TWD
